Therefore, in this study, we used multiple databases to analyze FCGR3A gene expression, prognosis, immune infiltration correlation, and epigenetic status in pan-cancer, and to explore the underlying molecular mechanisms and its relationship with drug sensitivity, so as to evaluate the impact of FCGR3A on the tumor microenvironment. The gene discussed is FCGR3A; the disease is cancer.